DKSH Indonesia strengthens its commitment to quality control, compliance, and safety in the pharmaceutical industry by obtaining a new license from the National Agency of Drug and Food Control (BPOM).
Jakarta, Indonesia, June 5, 2023 – DKSH's Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, has obtained a new license for its pharmaceutical industry business line from the National Agency of Drug and Food Control (BPOM) in Indonesia.
DKSH has a long-standing reputation for excellence in the global pharmaceutical industry. This license enables DKSH Indonesia's pharmaceutical team to expand its service offering, including regulatory, distribution, and global sourcing, for a wide range of high-quality pharmaceutical ingredients, including Active Pharmaceutical Ingredients (APIs) and excipients.
Ranti Endriani, Manager, Pharmaceutical Industry, DKSH Indonesia, stated: "We are delighted to receive this new license from BPOM, which recognizes our commitment to providing safe and effective pharmaceutical products to the Indonesian market. This license is a testament to our strong quality control systems, experienced technical expertise, and dedication to compliance with all relevant laws and regulations governing the pharmaceutical industry.”
Chookitch Thanakitkachorn, General Manager Performance Materials, DKSH Indonesia, added: "We are committed to maintaining the highest standards of quality and safety in everything we do, and this license from the National Agency of Drug and Food Control will enable us to continue to enrich people's lives in Indonesia with the best possible pharmaceutical ingredients."
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 37 markets with 32,600 specialists, generating net sales of CHF 11.3 billion in 2022. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care, and various industrial applications. With 53 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,650 specialists, the Business Unit generated net sales of CHF 1.5 billion in 2022. www.dksh.com/pm